EnviroTechnologies International Inc. (ETII)

[eztradin]

Might want to add this to the I-Box.

HNSO Information

Share Structure
Shares outstanding:  1,950,000,000

Insider positions: 775,000,000 Investor/GMD transaction
                                    295,000,000 Investors
                                    340,000,000 Officers
                       
Float:                            464,000,000
                                    300,000,000 Insiders
                                    164,000,000  Actual




Global Medical Direct GMD Acquisition:
http://www.globalmeddirect.com/
55 Employees
Over 15,000 retail customers

HNSO Acquired GMD on May 28, 2008
Global Medical Direct is located in Lenexa, Kansas, approximately 15 minutes south of Kansas City. Global Medical Direct maintains its call center, insurance center distribution center and sales and marketing at its Lenexa facility.
Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients lead healthier and more productive lives. Global Medical Direct provides an easy-to-use, cost effective and convenient way for patients to obtain their diabetes supplies and medications through their health plan, employer and government payors such as Medicare and Medicaid. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetic shoes and orthopedic inserts and diabetes maintenance medications.




Healthnostics and GMD Addressing the Expanding $92 Billion Diabetic Supply Market
NEW YORK--(Business Wire)--
Healthnostics, Inc. (Pink Sheets: HNSO), a medical and biotechnology information and technology company, is leveraging their relationship with GMD Inc. ("GMD") to expand GMD's leading position in the growing diabetes supply market. Healthnostics and GMD believe that because the diabetic supply market is portioned into mostly small and medium-sized companies the opportunities for GMD's growth and consolidation opportunities abound.

GMD is currently positioned to take full advantage of the growing demand for accessible and well priced diabetic products and supplies, and expects with such an expanding market to increase revenues in the next fiscal year beginning July 1, 2008.

Currently there are $92 Billion in direct health costs associated with diabetes. 54 million Americans are pre-diabetic, with nearly 15 million diagnosed with diabetes and 1.5 million more diagnosed each year, according to the Centers for Disease Control (CDC). This epidemic increases the overall risk for death among people with diabetes to about 2 times that of people without diabetes. GMD is supplying the products and drugs required for these millions of diabetic patients to maintain control of this life threatening disease.

"Healthnostics' and GMDs' management teams have the vision and experience to build a leading diabetic supply organization. Healthnostics brings the healthcare insight and development resources
to GMD that can only help capitalize on the great start GMD has made in penetrating this growing market," said Alan Grofe, President of Healthnostics and CEO of GMD.

Healthnostics Reports GMD, Inc. Maintains Record Revenue Pace for Fiscal Year Ending June 30, 2008
Monday June 16, 9:45 am ET
Audit Firm Search for GMD is Underway

NEW YORK--(BUSINESS WIRE)--Healthnostics, Inc. (OTC: HNSO - News), a medical and biotechnology information and technology company, is pleased to report that GMD Inc. (“GMD”) has maintained its new revenue booking pace for a record year. GMD reports on a fiscal year basis with its current year end at June 30, 2008. $10,000,000 in revenue for this fiscal year was previously projected and announced.

Healthnostics has also begun interviewing audit firms for GMD that are qualified to issue reports for publicly-traded companies. Further information upon selection and engagement of an audit firm will be forthcoming.

Alan Grofé, President of Healthnostics and CEO of GMD, Inc., commented, “I continue to be encouraged by the growth, new marketing possibilities and prospects for GMD. We will continue to provide updates on new developments as they unfold.”

For further information on Healthnostics’ companies, please visit www.healthnostics.com, GMD www.globalmeddirect.com, MedBioWorld www.medbioworld.com, MedNets www.mednets.com, and FamilyMedicalNet www.familymedicalnet.com.

Healthnostics (HNSO) Information
http://www.healthnostics.com/
7 Employees

Healthnostics, Inc. is a medical and biotechnology analytics company. Healthnostics provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals; and, utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals and the general public.

Operate the following website databases
www.medbioworld.com MediaBioWorld - one of the largest medical and biotechnology resource and reference portals on the Internet

www.mednets.com MedNets - a medical and consumer healthcare information portal

www.familymedicalnet.com FamilyMedicalNet - a consumer healthcare information portal

P.S.: Float should get pretty tight for a subber here after the
100M buyback which should start in 2 weeks.


To succeed in life. Share your wealth. Help others. God Bless.

EZtradin